Eye Drop Maker Agrees To Settle Claims Products Were Illegally Marketed

DENVER — A maker of a homeopathic eye drop has agreed to pay $3.57 million to settle class claims that it sold products without approval from U.S. Food and Drug Administration,...

Already a subscriber? Click here to view full article